EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $927,152 | -49.6% | 47,693 | -26.5% | 0.00% | -100.0% |
| Q1 2023 | $1,840,560 | +193.6% | 64,877 | +202.5% | 0.00% | – |
| Q4 2022 | $626,896 | +11.7% | 21,447 | +69.9% | 0.00% | – |
| Q2 2022 | $561,000 | +21.4% | 12,620 | +35.1% | 0.00% | – |
| Q1 2022 | $462,000 | +18.2% | 9,342 | +21.5% | 0.00% | – |
| Q4 2021 | $391,000 | +32.5% | 7,687 | +45.4% | 0.00% | – |
| Q3 2021 | $295,000 | -19.8% | 5,288 | -33.1% | 0.00% | – |
| Q4 2020 | $368,000 | -4.9% | 7,900 | -13.3% | 0.00% | – |
| Q3 2020 | $387,000 | +82.5% | 9,114 | +126.7% | 0.00% | -100.0% |
| Q1 2018 | $212,000 | -12.4% | 4,021 | +30.8% | 0.00% | 0.0% |
| Q2 2017 | $242,000 | +10.0% | 3,073 | +15.8% | 0.00% | 0.0% |
| Q1 2017 | $220,000 | -37.7% | 2,653 | -70.8% | 0.00% | -50.0% |
| Q2 2016 | $353,000 | -56.7% | 9,100 | -54.8% | 0.00% | -50.0% |
| Q1 2016 | $815,000 | +64.3% | 20,112 | +200.2% | 0.00% | +33.3% |
| Q3 2015 | $496,000 | +15.1% | 6,699 | +25.8% | 0.00% | 0.0% |
| Q2 2015 | $431,000 | +26.8% | 5,327 | -34.4% | 0.00% | 0.0% |
| Q1 2015 | $340,000 | – | 8,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |